Parkinson's Improvement Activated by Hula Understanding (PAHU) - Part 2

NCT07808606 | Enrolling By Invitation

• 1 other identifier: RA-2025-303
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

if hula can help quality of life, well being, balance and overall motor symptoms for individuals with Parkinson's disease.

Conditions

Parkinson' Disease

Keywords

hula, HrQOL

Outcome Measures

Primary Outcomes (1)

• Parkinson's Disease Questionnaire (PDQ-39)

  Parkinson's Disease Questionnaire (PDQ-39) is a commonly used 39-item scale to measure Helath related quality of life for patients with Parkinson's disease.The PDQ-39 ranges from 0 (lowest score, best quality of life) to 100 (highest score, worst quality of life). Higher the score, the worse outcome.

  prior to intervetion, 12 weeks, 24 weeks

Study Arms (2)

Intervention

ACTIVE COMPARATOR

24 weeks of hula

Behavioral: hula

delayed control intervention

OTHER

delayed start hula, for the second 12 weeks

Behavioral: hula

Interventions

hula BEHAVIORAL

one hour/week hula class tailored to Parkinson's

Intervention; delayed control intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Primary diagnosis of idiopathic PD confirmed by a movement disorder specialist.
• ≥ 18 years of age
• Ability to provide informed consent
• Ability to participate in an in-person 24-week hula program.
• Ability to complete all 3 balance tests (4SST, FTSTS, Quantitative Romberg Force Plate Measurement)

You may not qualify if:

• Presence of physical or mental health co-morbid conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical trial or to comply with follow-up requirements, or impact the scientific soundness of the clinical trial results.
• Drug or alcohol dependence that might interfere with safe participation, based on opinion of the PI.
• Inability to attend in-person hula classes and study visits at QMC.
• Patients with high fall risk.
• Contraindications for physical activity and/or hula classes specifically.

Sponsors & Collaborators

• University of Hawaii: lead

Study Sites (1)

The Queen's Medical Center

Honolulu, Hawaii, 96813, United States

Location

Related Publications (6)

• Kaholokula JK, Look M, Mabellos T, Ahn HJ, Choi SY, Sinclair KA, Wills TA, Seto TB, de Silva M. A Cultural Dance Program Improves Hypertension Control and Cardiovascular Disease Risk in Native Hawaiians: A Randomized Controlled Trial. Ann Behav Med. 2021 Oct 4;55(10):1006-1018. doi: 10.1093/abm/kaaa127.

  PMID: 33677520 BACKGROUND

• Sharp K, Hewitt J. Dance as an intervention for people with Parkinson's disease: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2014 Nov;47:445-56. doi: 10.1016/j.neubiorev.2014.09.009. Epub 2014 Sep 28.

  PMID: 25268548 BACKGROUND

• Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.

  PMID: 36602886 BACKGROUND

• LeWitt PA, Chaudhuri KR. Unmet needs in Parkinson disease: Motor and non-motor. Parkinsonism Relat Disord. 2020 Nov;80 Suppl 1:S7-S12. doi: 10.1016/j.parkreldis.2020.09.024. Epub 2020 Dec 19.

  PMID: 33349582 BACKGROUND

• GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.

  PMID: 30287051 BACKGROUND

• Bruno MK, Matsunaga M, Krening E, Nakagawa K, Chen JJ, Seto T, Gao F, Tanner C, Ross GW. Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's disease. Parkinsonism Relat Disord. 2024 Apr;121:106018. doi: 10.1016/j.parkreldis.2024.106018. Epub 2024 Feb 2.

  PMID: 38359475 BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Officials

• Michiko K Bruno, MD

  University of Hawaii

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Neurologist

Model Details: delayed start

Study Record Dates

• First Submitted: December 14, 2025
• First Posted: September 9, 2026
• Study Start: December 4, 2025
• Primary Completion: July 31, 2026
• Study Completion (Estimated): July 31, 2027
• Last Updated: September 9, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, ICF
• Time Frame: When approved by clincial trials.gov, 09/01/2026 for 3 years, 09/01/2029.
• Access Criteria: researchers via Clincal trials.gov and per request to investigators

Locations

US (1)